London: Relics of ancient viruses - that have spent millions of years hiding inside human DNA - help the body fight cancer, say scientists.
The study by the Francis Crick Institute in London showed the dormant remnants of these old viruses are woken up when cancerous cells spiral out of control.
This unintentionally helps the immune system target and attack the tumour.
The team wants to harness the discovery to design vaccines that can boost cancer treatment, or even prevent it.
The researchers had noticed a connection between better survival from lung cancer and a part of the immune system, called B-cells, clustering around tumours, BBC news reported.
B-cells are the part of our body that manufactures antibodies and are better known for their role in fighting off infections, such as Covid.
Precisely what they were doing in lung cancer was a mystery but a series of intricate experiments using samples from patients and animal tests showed they were still attempting to fight viruses.
Retroviruses have the nifty trick of slipping a copy of their genetic instructions inside our own.
Some of these foreign instructions have, over time, been co-opted and serve useful purposes inside our cells, but others are tightly controlled to stop them spreading.
However, chaos dominates inside a cancerous cell when it is growing uncontrollably and the once tight control of these ancient viruses is lost.
These ancient genetic instructions are no longer able to resurrect whole viruses but they can create fragments of viruses that are enough for the immune system to spot a viral threat.
The antibodies summon other parts of the immune system that kill off the "infected" cells - the immune system is trying to stop a virus but in this case is taking out cancerous cells.
The study, published in the journal Nature, describes how this happens naturally in the body but the researchers want to enhance that effect by developing vaccines to teach the body how to hunt for endogenous retroviruses.
The research came out of the TracerX study which has been tracking lung cancers in unprecedented detail and this week showed cancer's "near infinite" ability to evolve. It led the researchers running the trial to call for more focus on preventing cancer as it was so hard to stop.